Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $1.495B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,360,000 | $196M | 13.1% | $25.16 | — | COM | N5749R100 |
| VERA | VERA THERAPEUTICS INC | 3,165,000 | $136M | 9.1% | $8.35 | +326.7% | CL A | 92337R101 |
| NUVL | NUVALENT INC | 1,487,756 | $112M | 7.5% | $45.30 | +75.7% | COM | 670703107 |
| XENE | XENON PHARMACEUTICALS INC | 2,167,793 | $93.32M | 6.2% | $27.44 | +67.6% | COM | 98420N105 |
| SYRE | SPYRE THERAPEUTICS INC | 1,884,084 | $71.46M | 4.8% | $13.74 | +110.9% | COM NEW | 00773J202 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,973,245 | $69.89M | 4.7% | $18.48 | -17.0% | COM | 29337E102 |
| PCVX | VAXCYTE INC | 860,000 | $58.75M | 3.9% | $46.14 | +50.1% | COM | 92243G108 |
| — | MIND MEDICINE MINDMED INC | 5,833,333 | $54.83M | 3.7% | $9.40 | — | COM NEW | 60255C885 |
| — | ALPINE IMMUNE SCIENCES INC | 1,375,000 | $54.51M | 3.6% | $9.30 | — | COM | 02083G100 |
| ARVN | ARVINAS INC | 1,275,000 | $52.63M | 3.5% | $27.76 | +57.4% | COM | 04335A105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1,050,000 | $45.5M | 3.0% | $22.39 | +95.4% | COM | 76243J105 |
| COGT | COGENT BIOSCIENCES INC | 6,425,000 | $43.18M | 2.9% | $8.56 | -27.8% | COM | 19240Q201 |
| PHVS | PHARVARIS N V | 1,725,000 | $39.86M | 2.7% | $23.63 | +12.4% | COM | N69605108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 866,468 | $36.37M | 2.4% | $32.99 | +24.5% | COM NEW | 15117B202 |
| NKTX | NKARTA INC | 3,165,000 | $34.21M | 2.3% | $3.66 | +183.8% | COM | 65487U108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,934,653 | $33.88M | 2.3% | $17.59 | +10.2% | COM | 92790C104 |
| CELC | CELCUITY INC | 1,555,954 | $33.61M | 2.2% | $18.27 | -12.6% | COM | 15102K100 |
| KURA | KURA ONCOLOGY INC | 1,525,000 | $32.53M | 2.2% | $14.92 | +30.3% | COM | 50127T109 |
| CCCC | C4 THERAPEUTICS INC | 3,410,384 | $27.86M | 1.9% | $2.28 | +239.9% | COM STK | 12529R107 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,000,000 | $27.5M | 1.8% | $11.88 | 0.0% | COM | 68622P109 |
| ABVX | ABIVAX SA | 1,895,003 | $27.1M | 1.8% | $10.70 | — | SPONSORED ADS | 00370M103 |
| — | PERSPECTIVE THERAPEUTICS INC | 21,052,631 | $25.05M | 1.7% | $1.19 | — | COM | 46489V104 |
| IMVT | IMMUNOVANT INC | 750,990 | $24.26M | 1.6% | $14.46 | +152.4% | COM | 45258J102 |
| KYTX | KYVERNA THERAPEUTICS INC | 912,189 | $22.66M | 1.5% | $27.84 | 0.0% | COM | 501976104 |
| ENGN | ENGENE HOLDINGS INC | 1,250,000 | $21.19M | 1.4% | $12.24 | 0.0% | COM | 29286M105 |
| APGE | APOGEE THERAPEUTICS INC | 290,000 | $19.27M | 1.3% | $25.01 | +74.5% | COM | 03770N101 |
| CABA | CABALETTA BIO INC | 1,100,000 | $18.77M | 1.3% | $7.66 | +180.3% | COM | 12674W109 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 2,300,000 | $14.67M | 1.0% | $6.38 | — | SPON ADS | 05280R100 |
| — | THIRD HARMONIC BIO INC | 1,250,000 | $11.8M | 0.8% | $11.87 | — | COM | 88427A107 |
| NGNE | NEUROGENE INC | 200,000 | $10.18M | 0.7% | $33.40 | 0.0% | COM | 64135M105 |
| — | ADVERUM BIOTECHNOLOGIES INC | 657,333 | $9.295M | 0.6% | $14.14 | — | COM NEW | 00773U207 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,575,000 | $8.316M | 0.6% | $4.44 | +8.3% | COM | 92840H400 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 318,851 | $7.589M | 0.5% | $22.30 | 0.0% | COM | 87164F105 |
| SLNO | SOLENO THERAPEUTICS INC | 169,533 | $7.256M | 0.5% | $6.05 | +647.3% | COM | 834203309 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5.2M | 0.3% | $10.35 | 0.0% | CL A ORD SHS | G4444H101 |
| MGNX | MACROGENICS INC | 295,020 | $4.343M | 0.3% | $15.11 | 0.0% | COM | 556099109 |
| — | ADICET BIO INC | 1,374,320 | $3.23M | 0.2% | $2.35 | — | COM | 007002108 |
| SABS | SAB BIOTHERAPEUTICS INC | 183,174 | $832K | 0.1% | $8.38 | -34.3% | COM NEW | 78397T202 |
| — | DBV TECHNOLOGIES S A | 92,687 | $69,432 | 0.0% | $1.53 | — | SPONSORED ADR | 23306J101 |